Similarly, in this study, we also found that the ACSL6 expression was obviously increased in CRC samples compared to that in the control, and high expression of ACSL6 is correlated with favorable survival outcomes in CRC patients. The gene discussed is ACSL6; the disease is colorectal carcinoma.